Author/Creator
- National Cancer Institute (U.S.)5
- United States. General Accounting Office2
- American Association for Cancer Research1
- Datamonitor (Firm)1
- National Cancer Institute (U.S.), issuing body1
- National Cancer Institute (U.S.). Cancer Therapy Evaluation Program. Investigational Drug Branch1
- National Cancer Institute (U.S.). Cancer Therapy Evaluation Program. Investigational Drug Branch. Phase I Working Group. Meeting (1992 : National Library of Medicine)1
- National Cancer Institute (U.S.). Division of Cancer Prevention1
- National Cancer Institute (U.S.). Division of Cancer Prevention and Control1
- Prasad, Vinayak K., 1982-1
- Quality Enhancement Research Initiative (U.S.)1
- Shekelle, Paul G.1
- United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations1
- United States. Congress. Senate. Committee on Labor and Human Resources1
- United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Investigations and General Oversight1
- United States. Department of Veterans Affairs. Health Services Research and Development Service, issuing body1
- West Los Angeles VA Medical Center. Evidence-Based Synthesis Program Center1